Hamer, H <br/><br/>
[Effect of the German Act on the reform of the market for medicinal products (AMNOG) on the quality of neurological and psychiatric treatment].  [electronic resource] 

 -  Der Nervenarzt  Apr 2016 
 - 351-2 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1433-0407 
<br/><br/><label>Standard No.: </label>10.1007/s00115-016-0102-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Approval--economics<br/>Drug Industry--legislation & jurisprudence<br/>Germany<br/>Government Regulation<br/>Health Care Reform--economics<br/>Legislation, Drug<br/>Marketing of Health Services--economics<br/>Neurology--economics<br/>Outcome Assessment, Health Care--economics<br/>Psychotherapy--economics<br/>Quality Assurance, Health Care--economics